PDT Partners’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-60,164
| Closed | -$910K | – | 971 |
|
|
2022
Q3 | $910K | Sell |
60,164
-96,873
| -62% | -$1.47M | 0.14% | 249 |
|
|
2022
Q2 | $1.18M | Sell |
157,037
-3,878
| -2% | -$29.1K | 0.1% | 341 |
|
|
2022
Q1 | $1.46M | Buy |
160,915
+120,498
| +298% | +$1.1M | 0.13% | 246 |
|
|
2021
Q4 | $284K | Buy |
+40,417
| New | +$284K | 0.02% | 686 |
|
|
2021
Q3 | – | Sell |
-93,136
| Closed | -$1.49M | – | 962 |
|
|
2021
Q2 | $1.49M | Buy |
93,136
+30,993
| +50% | +$496K | 0.1% | 305 |
|
|
2021
Q1 | $1.11M | Sell |
62,143
-1,867
| -3% | -$33.3K | 0.08% | 353 |
|
|
2020
Q4 | $865K | Buy |
+64,010
| New | +$865K | 0.06% | 354 |
|
|
2014
Q2 | – | Sell |
-10,734
| Closed | -$227K | – | 1714 |
|
|
2014
Q1 | $227K | Buy |
+10,734
| New | +$227K | 0.01% | 1200 |
|